Skip to main content
KRYS logo
KRYS
(NASDAQ)
Krystal Biotech, Inc.
$302.05-- (--)
Loading... - Market loading

Krystal Biotech (KRYS) Stock Price & Financial Analysis

Krystal Biotech Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$296.13 - $303.37
52-Week High$315.17
52-Week Low$122.80
Open$297.09
Volume197.09K
Average Volume (3M)295.57K
Market Cap8.95B
Shares Outstanding30.51M
P/E Ratio (TTM)39.76
Forward P/E22.19
Price to Sales (P/S)21.44
Price to Book (P/B)7.01
EV/EBITDA47.28
Revenue (TTM)417.30M
Net Income (TTM)225.03M
Free Cash Flow (TTM)237.38M
EPS (TTM)$7.50
Profit Margin53.92%
Operating Margin42.85%
Return on Equity (ROE)17.63%
Debt to Equity0.01
50-Day MA$265.82
200-Day MA$222.92
52-Week Change124.40%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Krystal Biotech

What is the current stock price for KRYS?

As of the latest trading session, KRYS stock trades at $302.05. The 52-week range is $122.80–$315.17, with a day range of $296.13–$303.37.

What is the P/E ratio for KRYS?

Krystal Biotech's trailing P/E ratio is 39.8, meaning investors pay $39.8 for every $1 of annual earnings. The forward P/E is 22.2, reflecting analyst expectations for future earnings.

Does KRYS pay dividends?

Krystal Biotech does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for KRYS?

Based on 2 analysts, the consensus for KRYS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of KRYS?

Krystal Biotech's market capitalization is $9.21B, classifying it as a mid-cap company..